参考文献/References:
［1］ NENTWICH MM，ULBIG MW.Diabetic retinopathy-ocular com-plications of diabetes mellitus［J］.World J Diabetes，2015，6(3)：489-499.
［2］ LE JAN S，AMY C，CAZES A，MONNOT C，LAMANDE N，FAVIER J，et al.Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma［J］.Am J Pathol，2003，162(5)：1521-1528.
［3］ SANTULLI G.Angiopoietin-like proteins：a comprehensive look［J］.Front Endocrinol，2014，5:4.
［4］ XU A，LAM MC，CHAN KW，WANG Y，ZHANG J，HOO RL，et al.Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice［J］.Proc Natl Acad Sci USA，2005，102(17)：6086-6091.
［5］ VAN RAALTE DH，BRANDS M，SERLIE MJ，MUDDE K，STIENSTRA R，SAUERWEIN HP，et al.Angiopoietin-like protein 4 is differentially regulated by glucocorticoids and insulin in vitro and in vivo in healthy humans［J］.Exp Clin Endocrinol Diabetes，2012，120(10):598-603.
［6］ 刘云涛，简磊，潘敬芳.早期糖尿病慢性肾脏疾病患者血清血管生成素样蛋白4水平及吡格列酮影响的观察［J］.中国糖尿病杂志，2015，23(4):135-139.
LIU YT,JIAN L,PAN JF.The serum ANGPTL4 level in patients with early chronic kidney disease in diabetes and the influence of pioglitazone on the level［J］.Chin J Diabetes,2015,23(4):135-139.
［7］ CILENSEK I，MANKOC S，GLOBOCNIK PETROVIC M，PETROVIC D.The 4 a/4 a genotype of the VNTR polymorphism for endothelial nitric oxide synthase (eNOS) gene predicts risk for proliferative diabetic retinopathy in Slovenian patients (Caucasians) with type 2 diabetes mellitus［J］.Mol Biol Rep，2012，39(6):7061-7067.
［8］ SANG DN，D’AMORE PA.Is blockade of vascular endothelial growth factor beneficial for all types of diabetic retinopathy［J］?Diabetologia，2008，51(9):1570-1573.
［9］ YOKOUCHI H，ETO K，NISHIMURA W，TAKEDA N，KABURAGI Y，YAMAMOTO S，et al.Angiopoietin-like protein 4 (ANGPTL4) is induced by high glucose in retinal pigment epithelial cells and exhibits potent angiogenic activity on retinal endothelial cells［J］.Acta Ophthalmol，2013，91(4):e289-e297.
［10］ HUANG RL，TEO Z，CHONG HC，ZHU P，TAN CK，LAM CR，et al.ANGPTL4 modulates vascular junction integrity by integrin signaling and disruption of intercellular VE-cadherin and claudin-5 clusters［J］.Blood，2011，118(14):3990-4002.
［11］ XIN X，RODRIGUES M，UMAPATHI M，KASHIWABUCHI F，MA T，BABAPOOR-FARROKHRAN S，et al.Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4［J］.Proc Natl Acad Sci USA，2013，110(36):E3425-E3434.
［12］ BANDELLO F，CORVI F，LA SPINA C，BENATTI L，QUERQUES L，CAPUANO V，et al.Outcomes of intravitreal anti-VEGF therapy in eyes with both neovascular age-related macular degeneration and diabetic retinopathy［J］.Br J Ophthalmol，2016，100(12):1611-1616.
［13］ BABAPOOR-FARROKHRAN S，JEE K，PUCHNER B，HASSAN SJ，XIN X，RODRIGUES M，et al.Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy［J］.Proc Natl Acad Sci USA，2015，112(23):E3030-E3039.
［14］ LU Q，ZOU W，CHEN B，ZOU C，ZHAO M，ZHENG Z.ANGPTL-4 correlates with vascular endothelial growth factor in patients with proliferative diabetic retinopathy［J］.Graefes Arch Clin Exp Ophthalmol，2016，254(7):1281-1288.
［15］ MEHTA N，QAMAR A，QU L，QASIM AN，MEHTA NN，REILLY MP，et al.Differential association of plasma angiopoietin-like proteins 3 and 4 with lipid and metabolic traits［J］.Arterioscler Thromb Vasc Biol，2014，34(5):1057-1063.
相似文献/References:
[1]董敬远 刘瑶 吴晓艳.玻璃体切割联合白内障手术治疗增生性糖尿病视网膜病变[J].眼科新进展,2012,32(5):000.
[2]刘敬花 李松峰 卢海.23G微创玻璃体切割术在增生性糖尿病视网膜病变治疗中的应用[J].眼科新进展,2012,32(11):000.
[3]王丁丁 陈子林 周慧兰 宋青山.重硅油填充治疗增生性糖尿病视网膜病变的临床研究[J].眼科新进展,2013,33(1):000.
[4]陈明 蔡小军 胡梅 张启明 王永力.玻璃体切割联合超声乳化人工晶状体植入术治疗白内障合并PDR临床分析[J].眼科新进展,2013,33(9):000.
[5]张英楠 陈晓隆.玻璃体切割术治疗增生性糖尿病视网膜病变的临床疗效分析[J].眼科新进展,2012,32(1):000.
[6]罗毅,梅海峰.微创玻璃体切割联合超声乳化术治疗增生性糖尿病视网膜病变的疗效观察[J].眼科新进展,2014,34(6):577.[doi:10.13389/j.cnki.rao.2014.0159]
[7]蒋乐文,曹燕. 玻璃体切割术对增生性糖尿病视网膜病变患者黄斑区视网膜的影响[J].眼科新进展,2014,34(7):672.[doi:10.13389/j.cnki.rao.2014.0184]
[8]章晖,叶波,邱新文,等.雷珠单抗辅助23G玻璃体切割术治疗增生性糖尿病视网膜病变[J].眼科新进展,2014,34(10):975.[doi:10.13389/j.cnki.rao.2014.0270]
[9]詹冬梅,史琴,哈玲芳,等. 两种联合术式人工晶状体植入术治疗增生性糖尿病视网膜病变的对比研究[J].眼科新进展,2015,35(3):266.[doi:10.13389/j.cnki.rao.2015.0071]
ZHAN Dong-Mei,SHI Qin,HA Ling-Fang,et al. Comparative study of vitrectomy combined with phacoemulsification or pars plana lensectomy for proliferative diabetic retinopathy[J].Recent Advances in Ophthalmology,2015,35(1):266.[doi:10.13389/j.cnki.rao.2015.0071]
[10]时倩倩,刘华,付蓉花. 全视网膜光凝术对增生性糖尿病视网膜病变患者黄斑区视网膜功能的影响[J].眼科新进展,2015,35(4):362.[doi:10.13389/j.cnki.rao.2015.0097]
SHI Qian-Qian,LIU Hua,FU Rong-Hua. Effects of panretinal photocoagulation on macular retina of patients with proliferative diabetic retinopathy[J].Recent Advances in Ophthalmology,2015,35(1):362.[doi:10.13389/j.cnki.rao.2015.0097]